Where Will AST SpaceMobile Be In 5 Years?
Ever tried to send a text from the Nevada desert…
Sell
43
TAK Quote, Financials, Valuation and Earnings
Last price:
$15.20
Seasonality move
:
3.15%
Day range:
$15.18 - $15.33
52-week range:
$12.58 - $15.43
Dividend yield:
4.07%
P/E ratio:
69.66x
P/S ratio:
1.63x
P/B ratio:
1.02x
Volume:
2.4M
Avg. volume:
2.1M
1-year change:
16.21%
Market cap:
$47.5B
Revenue:
$30.1B
EPS (TTM):
$0.22
Earnings Data
Next earnings date for TAK
Oct 31
2025
Most recent earnings per share
-$0.21
Missed by $0.21
(May 8/2025)
Consensus Estimate
--
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TAK Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $8B | -- | -- | -- | -- |
| 05/08/2025 | Q1 | $7.6B | $6.9B | -$0.21 | -- | -- |
| 01/30/2025 | Q4 | $7.3B | $7.5B | $0.05 | -- | -- |
| 10/31/2024 | Q3 | $7.2B | $7.9B | $0.19 | -- | -- |
| 07/31/2024 | Q2 | $6.8B | $7.7B | $0.19 | -- | -- |
| 05/09/2024 | Q1 | $5.8B | $7.1B | -$0.01 | -- | -- |
| 02/01/2024 | Q4 | $6.8B | $7.5B | $0.23 | -- | -- |
| 10/26/2023 | Q3 | -- | -- | -$0.11 | -- | -- |
| 07/27/2023 | Q2 | -- | -- | $0.21 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | $0.07 | -- | -- |
| 02/02/2023 | Q4 | -- | -- | $0.27 | -- | -- |
| 10/27/2022 | Q3 | -- | -- | $0.14 | -- | -- |
| 07/28/2022 | Q2 | -- | -- | $0.26 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | -$0.03 | -- | -- |
| 02/03/2022 | Q4 | -- | -- | $0.16 | -- | -- |
| 10/28/2021 | Q3 | -- | -- | $0.13 | -- | -- |
| 07/30/2021 | Q2 | -- | -- | $0.40 | -- | -- |
| 05/11/2021 | Q1 | -- | -- | $0.59 | -- | -- |
| 02/04/2021 | Q4 | -- | -- | $0.28 | -- | -- |
| 10/29/2020 | Q3 | -- | -- | $0.01 | -- | -- |
| 07/31/2020 | Q2 | -- | -- | $0.24 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | $0.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.10 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | $0.16 | -- | -- |
Takeda Pharmaceutical Earnings Questions
-
How Much did Takeda Pharmaceutical Generate in Revenue Last Quarter?
Takeda Pharmaceutical reported $6.9B worth of top line sales in its most recent quarter.
-
Did Takeda Pharmaceutical Beat Earnings Last Quarter?
Takeda Pharmaceutical announced earnings per share of -$0.21 which represents a miss of analyst forecast a -- per share.
-
Is Takeda Pharmaceutical Profitable?
Takeda Pharmaceutical reported $4.4B that represents $1.35 per share over the last quarter.
-
What is the Analyst Consensus for Takeda Pharmaceutical EPS Next Year?
Takeda Pharmaceutical's earnings are forecast to grow from $0.22 per share to -- per share next year representing an increase of --.
-
When is Takeda Pharmaceutical's Earnings Date?
Takeda Pharmaceutical's next earnings date is October 31, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TTD The Big Winner If Pharma Ads Are Banned?
Last week, Senators Bernie Sanders and Angus King introduced a…
Is Palantir Stock Overvalued?
By every traditional yardstick, including a price‑to‑sales well above 100,…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 48x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Sell
11
VEON alert for Jun 14
VEON [VEON] is down 18.57% over the past day.
Buy
74
DAVE alert for Jun 14
Dave [DAVE] is down 12.68% over the past day.
Buy
54
DAR alert for Jun 14
Darling Ingredients [DAR] is up 9.12% over the past day.
